Home    Medline Search    Associations   Skin disorders    Departments   Atlas 1 Educational    Journals    Atlas  2    conference     PDA download              

 

Journal of the American Academy of Dermatology
Volume 52 • Number 6 • June 2005
Copyright © 2005 American Academy of Dermatology, Inc.

Letter

Assessment scale used in vitiligo



Delwar Hossain, DD
 


Assistant Professor, Department of Dermatology and Venereology, USTC/Foy's Lake/Chittagong, GPO BOX-1079, Bangladesh



 

To the Editor: During the last 5 years, several researchers have published their papers on different treatments for vitiligo. They used varied assessment scales to categorize the outcomes of their studies (Table I). Studies show a fair agreement in grading poor and excellent responses (0%-25% and 76%-100%, respectively) and a disagreement in grading other responses (those falling in the range of 26%-50% and 51%-75%). For instance, Radakovic-Fijan et al1 labeled them as moderate and marked responses, respectively, while Grimes et al2 considered them as mild and moderate responses. And another group (Scherschun et al3) recognized both ranges collectively as poor response.


 
Table I . Assessment scales in vitiligo
  Percent clearance and classification  
Treatment type 0%-25% 26%-50% 51%-75% 76%-100% Authors
Medical          
  Poor Fair Good Excellent Hann et al6
  Poor Moderate Good Excellent Yalcin et al7
  Slight Moderate Marked Excellent Radakovic-Fijan et al1
  Minimal Mild Moderate Excellent Grimes et al2
Narrowband ultraviolet B radiation          
  <25% Response Between 26%-75% response >75% response Njoo et al8
    Poor response   Best response Scherschun et al3
Surgical          
  Grade 1 Grade 2 Grade 3 Spencer et al4
  <10% as no repigmentation >10%-<95% as partial repigmentation >95% as complete repigmentation Kim et al5

Surgical studies leave the reader more puzzled. For example, Spencer et al4 graded 50% and 80% responses as considerable and excellent, respectively, while Kim et al5 labeled them as partial response only.

Moreover, almost all researchers had considered more than 75% response as equivalent to “complete response” behind the scenes. In fact, it may reflect a great achievement for the researchers/physicians, but it may not be significant to the same extent to patients with lesions over exposed anatomical sites who live with intense psycho-social suffering, and who usually desire to consider only 100% remission in all the treated lesions as a “complete cure.”

From the above mentioned facts, it can be concluded that existing assessment scales are not unambiguous. Instead, they are full of subjectivity, they do not reflect therapeutic outcomes accurately, and they do not reflect the patient's desire properly.

We know that vitiligo lesions usually show three patterns of response (diffuse yellowish tint, gradual reduction in size, and folliculo-centric re-pigmentation). And hence we should have a scale that reflects all these therapeutic responses accurately yet remains objective.

We have developed such an assessment scale (Table II). It has 5 grades: no response (-), mild response (+), moderate response (++), marked response (+++), and complete response (++++). It is more scientific, simple, unambiguous, and objective. It reflects treatment status more accurately and is more in line with a patient's acceptance. It is well fitted for scientific studies. We hope that this will eliminate the inherent drawbacks of the existing scale used in assessing the outcome of medical treatment of vitiligo. We also hope that this scale will get its due consideration and recognition.


 
Table II . Assessment scale proposed by Hossain
Parameter - + ++ +++ ++++
Change in color No change Yellowish tint Slight contrast between lesion color and surrounding skin color No contrast between lesion color and surrounding skin color 100% remission in all treated lesions
Change in size No change Up to 5 mm reduction in diameter Up to 10 mm reduction in diameter More than 10 mm reduction in diameter  
Folliculocentric repigmentation No repigmentation Up to 5 mm perifollicular repigmentation Up to 10 mm perifollicular repigmentation More than 10 mm perifollicular repigmentation  
 
-, No response; +, mild response; ++, moderate response; +++, marked response; ++++, complete response.


REFERENCES:
1  Radakovic-Fijan S.,  Furnsinn-Friedl A.M.,  Honigsmann H.,  Tanew A.,  Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol (2001) 44 : pp 814-817.  
2  Grimes P.E.,  Soriano T.,  Dytoc M.T.,  Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol (2002) 47 : pp 789-791.  
3  Scherschun L.,  Kim J.J.,  Lim H.W.,  Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol (2001) 44 : pp 999-1003.  
4  Spencer J.M.,  Nossa R.,  Ajmeri J.,  Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol (2002) 46 : pp 727-731.  
5  Kim H.Y.,  Kang K.Y.,  Epidermal grafts for treatment of stable and progressive vitiligo. J Am Acad Dermatol (1999) 40 : pp 412-417.  
6  Hann S.K.,  Kim Y.S.,  Yoo J.H.,  Chun Y.S.,  Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol (2000) 42 : pp 589-596.  
7  Yalcin B.,  Sahin S.,  Bukulmez G.,  Karaduman A.,  Atakan N.,  Akan T.,  Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol (2001) 44 : pp 634-637.  
8  Njoo M.D.,  Bos J.D.,  Westerhof W.,  Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol (2000) 42 : pp 245-253.